Related Experiment Videos
[Platelet reactivity index by Grotemeyer]
J Koscielny1, O Meyer, H Kiesewetter
1Institut für Transfusionsmedizin, Charité, Universitätsmedizin Berlin, Campus Charité Mitte, Schumannstr. 20/21, 10117 Berlin. juergen.koscielny@charite.de
Hamostaseologie
|August 18, 2004
Summary
The platelet reactivity index (PR) is a quick and affordable test to assess platelet aggregation, helping identify patients who may not respond to aspirin therapy for stroke and cardiac ischemia.
Area of Science:
- Hematology
- Biomedical Engineering
- Medical Diagnostics
Context:
- The determination of circulating platelet aggregates is crucial for understanding thrombotic events.
- Previous methods for assessing platelet aggregation have been refined over time.
- The Platelet Reactivity Index (PR) offers a streamlined approach to evaluating platelet function.
Purpose:
- To describe the Platelet Reactivity Index (PR) as a method for determining circulating platelet aggregates.
- To highlight the diagnostic utility of PR in identifying patients with abnormal platelet aggregation.
- To evaluate the effectiveness of PR in predicting response to antiplatelet therapy.
Summary:
- The PR method utilizes differential buffer solutions to measure platelet aggregates, with results automatically estimated.
- Elevated PR values (above 1.05 or 1.2) indicate increased platelet aggregation and potential pathological changes.
- The PR test is cost-effective and rapid, proving successful in identifying non-responders to aspirin therapy in stroke and cardiac ischemia patients.
Impact:
- PR values correlate significantly with arterial thromboembolic complications.
- The PR demonstrates strong correlation with other established platelet function tests like RT-H and PFA-100.
- PR serves as a predictive tool for evaluating aspirin therapy efficacy, although not for determining overdosage.